Results 271 to 280 of about 236,531 (317)

Testosterone Replacement Therapy and Prostate Health

Current Urology Reports, 2012
There is an emerging evolution in the understanding of the relationship between the prostate and testosterone. It has long been generally believed that with testosterone replacement therapy (TRT), increasing serum testosterone levels led to prostatic growth and worsening of voiding dysfunction and associated complications.
A Scott, Polackwich, Kevin A, Ostrowski, Jason C, Hedges   +2 more
openaire   +2 more sources

Testosterone replacement therapy: For whom, when and how?

Metabolism: Clinical and Experimental, 2018
The finding of low circulating testosterone level in men is relatively frequent. The symptoms of hypogonadism are very frequent in the aging men. However, the diagnosis of hypogonadism is often neglected and the opportunity to replace low testosterone in
C. Tsametis, A. Isidori
semanticscholar   +1 more source

Hormone Therapy: Testosterone Replacement Therapy.

FP essentials, 2023
Testosterone levels decrease as men age. When the testes fail to produce an adequate level of endogenous testosterone, men develop hypogonadism. Although the definition of a low testosterone level varies among guidelines, a serum total testosterone level of less than 300 to 350 ng/dL on two separate morning blood samples is considered a low level.
openaire   +1 more source

Advances in Testosterone Replacement Therapy

2008
The major goal of androgen substitution is to replace testosterone at levels as close to physiological concentrations as is possible. The mainstay of testosterone susbstitution are parenteral testosterone esters (enanthate and cypionate) to be administered every 2-3 weeks.
openaire   +4 more sources

Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure

Journal of Cardiovascular Pharmacology and Therapeutics, 2018
Background: Testosterone deficiency is associated with heart failure (HF) progression and poor prognosis. Testosterone therapy has been shown to improve exercise capacity in patients with chronic HF, but no trial has evaluated the impact of replacement ...
M. Navarro-Peñalver, M. T. Pérez-Martínez, M. Gómez-Bueno, P. García-Pavía, J. Lupón-Rosés, Eulalia Roig-Minguell, J. Comín-Colet, A. Bayés‐Genís, J. A. Noguera, Domingo A. Pascual-Figal, Domingo A. Pascual-Figal   +10 more
semanticscholar   +1 more source

Blood donation and testosterone replacement therapy

Transfusion, 2017
BACKGROUNDPolycythemia is the most common adverse effect of testosterone replacement therapy (TRT) and may predispose patients to adverse vascular events. Current Canadian guidelines recommend regular laboratory monitoring and discontinuing TRT or reducing the dose if the hematocrit exceeds 54% (hemoglobin ≥180 g/L). This threshold has been interpreted
Benjamin, Chin-Yee, Alejandro, Lazo-Langner, Terrie, Butler-Foster, Cyrus, Hsia, Ian, Chin-Yee   +4 more
openaire   +2 more sources

Testosterone replacement therapy in male hypogonadism

Journal of Endocrinological Investigation, 2003
In human males 6-7 mg of testosterone are secreted by the testes in a circadian rhythm with a nocturnal rise in testosterone followed by a decline during the day. Testosterone is necessary to induce and maintain secondary sexual characteristics, lean muscle mass, bone density and for normal sexual behaviour and cognitive function in men.
M, Byrne, E, Nieschlag
openaire   +2 more sources

Men behaving madly: testosterone replacement therapy

BMJ, 2010
When young, they get overexcited, climb trees, and fight. As adolescents, their earphones blare out thrash metal, and they grunt in response to any question. Testosterone makes them spotty, hairy, and moody, and sport becomes their only social expression.
openaire   +2 more sources

[Andrological testosterone replacement therapy].

Der Urologe. Ausg. A, 2009
Male hypogonadism is characterised by decreased testicular function, especially testosterone deficiency. Its prevalence increases with age but may be acquired in all stages of life if it is not inborn. The lack of testosterone results in typical clinical symptoms. However, only about 10% of the affected men currently receive adequate treatment.
U, Paasch, H-J, Glander, J-U, Stolzenburg   +2 more
openaire   +1 more source

Testosterone Replacement Therapy and Prostate Cancer

Urologic Clinics of North America, 2007
The long-standing concern that testosterone replacement therapy (TRT) may increase the risk of prostate cancer (PCa) has come under new scrutiny. Arguments used to support this concern lack a scientific basis. The original assertion by Huggins that administration of testosterone (T) caused "enhanced growth" of PCa was based on only a single patient ...
openaire   +2 more sources